AMRUTANJAN

Amrutanjan Health Care Share Price

₹598.40 +0.65 (0.11%)

22 Feb, 2025 21:34

SIP TrendupStart SIP in AMRUTANJAN

Start SIP

Performance

  • Low
  • ₹593
  • High
  • ₹608
  • 52 Week Low
  • ₹586
  • 52 Week High
  • ₹863
  • Open Price₹602
  • Previous Close₹598
  • Volume15,990

Investment Returns

  • Over 1 Month -12.04%
  • Over 3 Month -15.18%
  • Over 6 Month -23.42%
  • Over 1 Year -11.59%
SIP Lightning

Smart Investing Starts Here Start SIP with Amrutanjan Health Care for Steady Growth!

Invest Now

Amrutanjan Health Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.1
  • PEG Ratio
  • 2.9
  • Market Cap Cr
  • 1,730
  • P/B Ratio
  • 5.8
  • Average True Range
  • 26.78
  • EPS
  • 17.06
  • Dividend Yield
  • 0.8
  • MACD Signal
  • -21.41
  • RSI
  • 32.2
  • MFI
  • 33

Amrutanjan Health Care Financials

Amrutanjan Health Care Technicals

EMA & SMA

Current Price
₹598.40
+ 0.65 (0.11%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹636.55
  • 50 Day
  • ₹671.84
  • 100 Day
  • ₹698.25
  • 200 Day
  • ₹707.45

Resistance and Support

599.82 Pivot Speed
  • R3 620.33
  • R2 613.97
  • R1 606.18
  • S1 592.03
  • S2 585.67
  • S3 577.88

What's your outlook on Amrutanjan Health Care?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Amrutanjan Health Care Ltd. manufactures and markets healthcare products, including pain balms, headache relief solutions, and beverages. Known for its traditional and Ayurvedic formulations, it serves consumers across India with a focus on natural, safe, and effective remedies.

Amrutanjan Health Care has an operating revenue of Rs. 443.46 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 15% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 47 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Amrutanjan Health Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-12 Quarterly Results & Interim Dividend
2024-11-12 Quarterly Results & Interim Dividend
2024-08-13 Quarterly Results
2024-05-23 Audited Results & Final Dividend
2024-02-09 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-02-18 INTERIM Rs.1.00 per share(100%)Second Interim Dividend
2024-11-22 INTERIM Rs.1.00 per share(100%)First Interim Dividend (RD & XD dates revised)
2024-02-20 INTERIM Rs.1.00 per share(100%)Second Interim Dividend
2023-11-23 INTERIM Rs.1.00 per share(100%)Interim Dividend
2023-09-14 FINAL Rs.2.60 per share(260%)Final Dividend
View More

Amrutanjan Health Care F&O

Amrutanjan Health Care Shareholding Pattern

46.52%
9.21%
2.3%
0.09%
33.73%
8.15%

About Amrutanjan Health Care

  • NSE Symbol
  • AMRUTANJAN
  • BSE Symbol
  • 590006
  • Chairman & Managing Director
  • Mr. S Sambhu Prasad
  • ISIN
  • INE098F01031

Similar Stocks to Amrutanjan Health Care

Amrutanjan Health Care FAQs

Amrutanjan Health Care share price is ₹598 As on 22 February, 2025 | 21:20

The Market Cap of Amrutanjan Health Care is ₹1730 Cr As on 22 February, 2025 | 21:20

The P/E ratio of Amrutanjan Health Care is 35.1 As on 22 February, 2025 | 21:20

The PB ratio of Amrutanjan Health Care is 5.8 As on 22 February, 2025 | 21:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23